Garheng Kong founded HealthQuest Capital in 2012 and serves as its Managing Partner. HealthQuest is a healthcare-focused private investment firm providing growth capital to companies seeking to improve value and outcomes across the healthcare system.

A physician, scientist, and engineer by training, Garheng has more than two decades of experience investing in innovative healthcare companies and has led more than 40 companies to successful IPO or M&A exits. He serves as Vice Chairman and Lead Independent Director of Labcorp and on the boards of Smith & Nephew, Xeris Biopharma, IKS Health, Duke University Health System, the Duke University Board of Trustees, Dell Children’s Foundation, UT Medicine, UT President’s Commercial Advisory Board, and the Austin Healthcare Council.

Garheng is an Aspen Institute Health Innovators Fellow, Kauffman Fellows Mentor, and member of YPO. He was named a Top 25 Healthcare Investor by GrowthCap in 2022, 2024, 2025, and 2026 and received the publication’s Healthcare Investor of the Year award for 2024. In 2023, BoardProspects recognized Garheng as one of the Top 30 Asian American and Pacific Islander Board Members in the U.S.

Garheng earned undergraduate degrees in Chemical Engineering and Biological Sciences from Stanford University, where he attended on an athletic scholarship. He later earned an MD, PhD, and MBA from Duke University, graduating at the top of his class in each instance. His early career included roles at GlaxoSmithKline, McKinsey & Company, TherOx, Intersouth Partners, and Sofinnova Investments.

Garheng and his wife, a physician and board-certified cardiac electrophysiologist, have three children. A former nationally ranked volleyball player, he remains an avid sports fan and “foodie.”